Analysen von Dominic Lunn

15.08.23 AstraZeneca Neutral Credit Suisse Group
11.08.23 Sartorius Stedim Biotech Neutral Credit Suisse Group
11.08.23 Sartorius vz. Neutral Credit Suisse Group
09.08.23 Bayer Neutral Credit Suisse Group
27.07.23 GSK Neutral Credit Suisse Group
25.07.23 Bayer Neutral Credit Suisse Group
20.06.23 Sartorius vz. Neutral Credit Suisse Group
12.05.23 Bayer Neutral Credit Suisse Group
28.04.23 AstraZeneca Neutral Credit Suisse Group
27.04.23 GSK Neutral Credit Suisse Group
21.04.23 Sartorius vz. Neutral Credit Suisse Group
18.04.23 Sartorius Stedim Biotech Neutral Credit Suisse Group
17.03.23 Sartorius vz. Neutral Credit Suisse Group
07.03.23 Bayer Neutral Credit Suisse Group
10.02.23 AstraZeneca Neutral Credit Suisse Group
02.02.23 Novo Nordisk Neutral Credit Suisse Group
02.02.23 GSK Neutral Credit Suisse Group
23.01.23 Sartorius vz. Neutral Credit Suisse Group
06.01.23 Bayer Neutral Credit Suisse Group
06.01.23 AstraZeneca Neutral Credit Suisse Group
06.01.23 GSK Neutral Credit Suisse Group
16.12.22 Bayer Neutral Credit Suisse Group
09.11.22 Bayer Neutral Credit Suisse Group
03.11.22 GSK Neutral Credit Suisse Group
03.11.22 Novo Nordisk Neutral Credit Suisse Group
05.10.22 AstraZeneca Neutral Credit Suisse Group
15.09.22 AstraZeneca Neutral Credit Suisse Group
15.09.22 GSK Neutral Credit Suisse Group
05.08.22 Bayer Neutral Credit Suisse Group
04.08.22 Novo Nordisk Neutral Credit Suisse Group
20.07.22 Novartis Neutral Credit Suisse Group
12.07.22 Novo Nordisk Neutral Credit Suisse Group
09.06.22 Bayer Neutral Credit Suisse Group
19.05.22 Roche Neutral Credit Suisse Group
11.05.22 Bayer Neutral Credit Suisse Group
27.04.22 Novartis Neutral Credit Suisse Group
26.04.22 Roche Neutral Credit Suisse Group
01.04.22 Novo Nordisk Neutral Credit Suisse Group
02.03.22 Bayer Neutral Credit Suisse Group
03.02.22 Novo Nordisk Neutral Credit Suisse Group
03.02.22 Novartis Neutral Credit Suisse Group
21.12.21 Bayer Neutral Credit Suisse Group
13.12.21 Roche Neutral Credit Suisse Group
13.12.21 Bayer Neutral Credit Suisse Group
13.12.21 Novartis Neutral Credit Suisse Group
04.11.21 Novo Nordisk Neutral Credit Suisse Group
27.10.21 Novartis Neutral Credit Suisse Group
21.10.21 Roche Neutral Credit Suisse Group
23.09.21 Roche Neutral Credit Suisse Group
23.08.21 Novo Nordisk Neutral Credit Suisse Group